CK Legal Chabasiewicz Kowalska has advised Ryvu Therapeutics on an EUR 8 million venture debt financing from the European Investment Bank. Allen & Overy reportedly advised the EIB.
Ryvu Therapeutics is a Polish clinical-stage biopharmaceutical company developing novel small-molecule therapies that address emerging targets in oncology. The company is listed on the Warsaw Stock Exchange.
According to CK Legal, "this is the first tranche of financing, which will help Ryvu finance its development pipeline of new cancer treatments, from discovery to clinical trials."
Back in 2020, CK Legal advised Ryvu Therapeutics on a share offering (as reported by CEE Legal Matters on July 27, 2020).
The CK Legal team included Founding Partner Wojciech Chabasiewicz and Head of Capital Markets Anita Gwozdz.
Editor's Note: After this article was published, Allen & Overy confirmed it had advised the EIB. The firm's team included Partner Arkadiusz Pedzich, Counsels Lukasz Walczyna and Maciej Skoczynski, and Associates Jan Spierzak and Alicja Urbanska.
